<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>SB 658 (Edition 1)</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Times New \(W1\)";}
@font-face
	{font-family:IDAutomationHC39M;
	panose-1:2 0 5 9 0 0 0 2 0 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.25pt;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:23.75pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.MsoLineNumber
	{font-family:"Times New Roman",serif;}
p.LMSBase, li.LMSBase, div.LMSBase
	{mso-style-name:LMSBase;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aArticle, li.aArticle, div.aArticle
	{mso-style-name:aArticle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aArticleTitle, li.aArticleTitle, div.aArticleTitle
	{mso-style-name:aArticleTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBase, li.aBase, div.aBase
	{mso-style-name:aBase;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBillSection, li.aBillSection, div.aBillSection
	{mso-style-name:aBillSection;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock1, li.aBlock1, div.aBlock1
	{mso-style-name:aBlock1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock2, li.aBlock2, div.aBlock2
	{mso-style-name:aBlock2;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock3, li.aBlock3, div.aBlock3
	{mso-style-name:aBlock3;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock4, li.aBlock4, div.aBlock4
	{mso-style-name:aBlock4;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock5, li.aBlock5, div.aBlock5
	{mso-style-name:aBlock5;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aChapter, li.aChapter, div.aChapter
	{mso-style-name:aChapter;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aHeading, li.aHeading, div.aHeading
	{mso-style-name:aHeading;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aLongTitle, li.aLongTitle, div.aLongTitle
	{mso-style-name:aLongTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	text-transform:uppercase;}
p.aMargin1, li.aMargin1, div.aMargin1
	{mso-style-name:aMargin1;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aMargin2, li.aMargin2, div.aMargin2
	{mso-style-name:aMargin2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aPart, li.aPart, div.aPart
	{mso-style-name:aPart;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSection, li.aSection, div.aSection
	{mso-style-name:aSection;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSP, li.aSP, div.aSP
	{mso-style-name:aSP;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;
	font-weight:bold;}
p.aSPComment, li.aSPComment, div.aSPComment
	{mso-style-name:aSPComment;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	color:red;
	display:none;
	font-weight:bold;}
p.aSPFunds1, li.aSPFunds1, div.aSPFunds1
	{mso-style-name:aSPFunds1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPFunds2, li.aSPFunds2, div.aSPFunds2
	{mso-style-name:aSPFunds2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPFundsHeading1, li.aSPFundsHeading1, div.aSPFundsHeading1
	{mso-style-name:aSPFundsHeading1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSPFundsHeading2, li.aSPFundsHeading2, div.aSPFundsHeading2
	{mso-style-name:aSPFundsHeading2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSPHeading, li.aSPHeading, div.aSPHeading
	{mso-style-name:aSPHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.nonumber, li.nonumber, div.nonumber
	{mso-style-name:nonumber;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPHeadingLine, li.aSPHeadingLine, div.aSPHeadingLine
	{mso-style-name:aSPHeadingLine;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.ASPlist, li.ASPlist, div.ASPlist
	{mso-style-name:ASPlist;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.5in;
	margin-bottom:.0001pt;
	text-indent:-1.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPRequestedBY, li.aSPRequestedBY, div.aSPRequestedBY
	{mso-style-name:aSPRequestedBY;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";}
p.aSPTitle, li.aSPTitle, div.aSPTitle
	{mso-style-name:aSPTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	text-transform:uppercase;
	font-weight:bold;}
p.aSubChapter, li.aSubChapter, div.aSubChapter
	{mso-style-name:aSubChapter;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSubPart, li.aSubPart, div.aSubPart
	{mso-style-name:aSubPart;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aTitle, li.aTitle, div.aTitle
	{mso-style-name:aTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.cHistoryNote
	{mso-style-name:cHistoryNote;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;
	font-family:"Times New Roman",serif;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Times New Roman",serif;}
p.TOCPageHeader, li.TOCPageHeader, div.TOCPageHeader
	{mso-style-name:TOCPageHeader;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSPSubTitle, li.aSPSubTitle, div.aSPSubTitle
	{mso-style-name:aSPSubTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSPHeadingMiscellaneous, li.aSPHeadingMiscellaneous, div.aSPHeadingMiscellaneous
	{mso-style-name:aSPHeadingMiscellaneous;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aDistrict, li.aDistrict, div.aDistrict
	{mso-style-name:aDistrict;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:10.0pt;
	line-height:115%;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 11.0in;
	margin:.6in .9in .5in 1.2in;}
div.WordSection1
	{page:WordSection1;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=nonumber align=center style='margin-top:24.0pt;text-align:center'><b>GENERAL
ASSEMBLY OF NORTH CAROLINA</b></p>

<p class=nonumber align=center style='margin-top:3.0pt;margin-right:0in;
margin-bottom:6.0pt;margin-left:0in;text-align:center'><b>SESSION 2019</b></p>

<p class=nonumber align=left style='text-align:left'><b>S                                                                                                                                                     1</b></p>

<p class=nonumber align=center style='text-align:center'><b>SENATE BILL 658</b></p>

<p class=nonumber align=center style='text-align:center'><b>&nbsp;</b></p>

<p class=nonumber align=center style='text-align:center'><b>&nbsp;</b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=0
 style='width:6.55in;margin-left:-5.75pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=527 colspan=2 valign=top style='width:395.25pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-bottom:6.0pt;text-align:left'>Short
  Title:      Prescription Drug Pricing.</p>
  </td>
  <td width=102 valign=top style='width:76.35pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=right style='margin-bottom:6.0pt;text-align:right'>(Public)</p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.85pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Sponsors:</p>
  </td>
  <td width=533 colspan=2 valign=top style='width:399.75pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber style='margin-top:3.0pt;margin-right:0in;margin-bottom:
  3.0pt;margin-left:0in'>Senators Mohammed, Smith, and Van Duyn (Primary
  Sponsors).</p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.85pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Referred to:</p>
  </td>
  <td width=533 colspan=2 valign=top style='width:399.75pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber style='margin-top:3.0pt;margin-right:0in;margin-bottom:
  3.0pt;margin-left:0in'>Rules and Operations of the Senate</p>
  </td>
 </tr>
 <tr height=0>
  <td width=96 style='border:none'></td>
  <td width=431 style='border:none'></td>
  <td width=102 style='border:none'></td>
 </tr>
</table>

<p class=nonumber align=center style='margin-top:6.0pt;margin-right:0in;
margin-bottom:12.0pt;margin-left:0in;text-align:center'>April 4, 2019</p>

<p class=aBase align=center style='text-align:center'><span style='color:black'>A
BILL TO BE ENTITLED</span></p>

<p class=aLongTitle><span style='font-family:"Times New Roman",serif;
color:black'>AN ACT to promote prescription drug price transparency.</span></p>

<p class=aBase><span style='color:black'>The General Assembly of North Carolina
enacts:</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 1.</span></b><span
style='color:black'>  Chapter 66 of the General Statutes is amended by adding a
new Article to read:</span></p>

<p class=aArticle><span style='color:black'>&quot;<u>Article 48.</u></span></p>

<p class=aArticleTitle><span style='color:black'>&quot;<u>Prescription Drug Transparency.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 66&#8209;460.  Title.</span></u></p>

<p class=aMargin1><u><span style='color:black'>This Article shall be entitled &quot;The
Prescription Drug Transparency Act.&quot;</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 66&#8209;461.  Definitions.</span></u></p>

<p class=aMargin1><u><span style='color:black'>As used in this Article, the
following shall mean:</span></u></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Interested parties. – State agencies that
purchase prescription drugs or have employees who are prescribers, health
insurance companies, health care service plan providers, and pharmacy benefit
managers.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Manufacturer. – An entity engaged in producing,
preparing, propagating, compounding, processing, packaging, repackaging, or
labeling a brand&#8209;name or generic drug, but does not include an entity that
is engaged in the preparation and dispensing of a brand&#8209;name or generic
drug pursuant to a prescription.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Prescriber. – Any person authorized by State law
to issue a prescription order.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Prescription drug. – As defined in G.S&nbsp;90&#8209;85.3(s).</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>Prescription order. – As defined in G.S.&nbsp;90&#8209;85.3(t)</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>Secretary. – The Secretary of the North Carolina
Department of Health and Human Services.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(7)</span></u><span
style='color:black'>        <u>Substantial price increase. – Any increase in
the price charged by a manufacturer for a prescription drug that </u></span><u><span
style='color:black'>would have the impact of increasing a drug's cost by ten percent
(10%) or more over 12 months.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 66&#8209;462.  Required notifications and disclosures.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>Price Increases. – A manufacturer shall notify
all interested parties of an upcoming substantial price increase at least 60
days prior to the increase. Within 30 days of the notification required under
this subsection, the manufacturer shall disclose the following to all interested
parties:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>A</u></span><u><span style='color:black'>
justification for the proposed price increase. The manufacturer may limit the
information in the justification to that which is publicly available.</span></u></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>The previous year's marketing budget for the drug.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>The date and price of acquisition if the drug
was not developed by the manufacturer.</u></span></p>

<p class=aBlock1><u>(4)</u>        <u>A schedule of price increases for the
drug for the previous five years.</u></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>New Products. – A manufacturer shall notify all
interested parties of the price of any new prescription drug within three days
after the manufacturer receives approval by the U.S. Food and Drug
Administration. Within 30 days of the notification required under this
subsection, the manufacturer shall disclose the following to all interested
parties:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>A justification for the price. The manufacturer
may limit the contents of the justification to publicly available information.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>The expected marketing budget for the drug.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>The date and price of acquisition if the drug
was not developed by the manufacturer.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>Risk of Dependency. – </u></span><u><span
style='color:black'>If a manufacturer or an agent of the manufacturer meets or
otherwise communicates with a prescriber for the purpose of marketing a prescription
drug, the manufacturer or the manufacturer's agent shall disclose to the
prescriber if any ingredient in the prescription drug it is marketing is known
to pose a risk of dependency in humans.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 66&#8209;463.  Penalty for failure to report.</span></u></p>

<p class=aMargin1><u><span style='color:black'>A manufacturer that fails to
report the information required under G.S.&nbsp;66&#8209;462(a) and (b) shall
be fined by the Secretary the sum of one thousand dollars ($1,000) each day
until the manufacturer submits the required information.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 66&#8209;464.  No price limitations.</span></u></p>

<p class=aMargin1><u><span style='color:black'>Nothing in this Article shall be
construed as a limitation upon the ability of a manufacturer to charge any
price for a prescription drug permitted by law.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 66&#8209;465.  Report and data collection by the
Secretary; public portal.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>Plan for Implementation. – The Secretary </u></span><u><span
style='color:black'>shall develop a plan to collect data from manufacturers
related to the cost and pricing of prescription drugs in order to provide
transparency in and accountability for prescription drug pricing. The Secretary
shall consult with other state and national agencies and organizations to
determine how to institute such data collection. The Secretary shall submit a plan
regarding how to implement these requirements as well as any findings and
recommendations to the </span><span style='color:black'>Joint Legislative
Oversight Committee on Health and Human Services</span></u><u><span
style='color:black'> by February 1, 2020.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Public Portal. – The Secretary shall also
implement an online portal to provide the public with electronic access to the
notifications, reports, and other disclosures required by this Article.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>Annual Report. – Beginning December 1, 2020, and
annually thereafter, the Secretary shall report to the Joint Legislative
Oversight Committee on Health and Human Services the following information
about prescription drugs:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>The 25 most frequently prescribed drugs in the
State.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        </span><u><span style='color:black'>The 25
costliest drugs as determined by the total amount spent on those drugs in the
State.</span></u></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>The 25 prescription drugs with the highest year&#8209;over&#8209;year
cost increases as determined by the total amount spent on those drugs in the
State.</u>&quot;</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 2.</span></b><span
style='color:black'>  This act becomes effective October 1, 2019.</span></p>

</div>

</body>

</html>
